Your World Biomarkers & Diagnostics Event Series Schedule
Since 2010, the World Biomarkers & Diagnostics Event Series has been at the centre of the precision medicine community; uniting thought leaders and innovators across biomarker operations, solid tissue and liquid biopsy companion diagnostics, AI-enabled platforms and multimodal data, biomarker testing and IVD regulation.
Providing a much-needed platform for candid conversations on how to discover, validate, and translate meaningful biomarkers and diagnostic tools from bench-to-bedside, the series supports teams working to improve decision-making across the entire drug and device co-development lifecycle. Whether you are advancing early discovery biomarkers, designing next generation IVD trials, evaluating new diagnostic partners or enabling precision-guided therapies, this highly focused event series is dedicated to helping the right drug, reach the right patient, at the right time.
As pharma, biotech, diagnostic, technology and testing lab providers strive to develop more effective, scalable and equitable testing solutions for patients, join our global industry-leading meetings to share real-world experiences, compare emerging evidence, and accelerate the adoption of clinically impactful biomarker and diagnostic innovations in oncology and beyond.
Discover the Event Program
See where leading teams at AstraZeneca, Amgen, Pfizer and Johnson & Johnson are taking ctDNA next, from dose finding through to MRD endpoints.
Prioritize Partnering With Us
Place your liquid biopsy platform in front of the pharma teams choosing assay partners for their next trials, before the vendor landscape settles.
Join 250+ Biopharma Peers
Meet the translational and precision medicine experts shaping future liquid biopsy strategies, so you can return to your team with actionable plans to implement in 2027 and beyond.